Polyclonal Rabbit anti‑Human FBLN4 / EFEMP2 Antibody (60‑140 aa, Internal, IHC, IF, WB) LS‑C383495
Polyclonal Rabbit anti‑Human FBLN4 / EFEMP2 Antibody (60‑140 aa, Internal, IHC, IF, WB) LS‑C383495
Antibody:
FBLN4 / EFEMP2 Rabbit anti-Human Polyclonal (60-140 aa, Internal) Antibody
Application:
IHC, IF, WB, ELISA
Format:
Unconjugated, Unmodified
Overview
Antibody:
FBLN4 / EFEMP2 Rabbit anti-Human Polyclonal (60-140 aa, Internal) Antibody
Application:
IHC, IF, WB, ELISA
Format:
Unconjugated, Unmodified
Specifications
Description
EFEMP2 antibody LS-C383495 is an unconjugated rabbit polyclonal antibody to human EFEMP2 (FBLN4) (60-140 aa, Internal). Validated for ELISA, IF, IHC and WB.
Target
Human FBLN4 / EFEMP2
Synonyms
EFEMP2 | ARCL1B | FIBL-4 | Fibulin-4 | Fibulin 4 | Protein UPH1 | MBP1 | UPH1 | FBLN4 | Mutant p53 binding protein 1
Reactivity
Human
(tested or 100% immunogen sequence identity)
Conjugations
Unconjugated
Purification
Immunoaffinity purified
Immunogen
Synthesized peptide derived from human Fibulin-4
Epitope
60-140 aa, Internal
Specificity
Fibulin-4 Polyclonal Antibody detects endogenous levels of Fibulin-4 protein.
Applications
- IHC (1:100 - 1:300)
- Immunofluorescence (1:200 - 1:1000)
- Western blot (1:500 - 1:2000)
- ELISA (1:10000)
|
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents
ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
|
Presentation
PBS, 0.02% Sodium Azide, 50% Glycerol, 0.5% BSA
Storage
Store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Reactivity:
Human
Range:
3.12-200 ng/ml
Reactivity:
Human
Range:
3.125-200 ng/ml
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 2/12/2025